Table of Content

1. Executive Summary
   1.1. Global Autism Spectrum Disorder Treatment Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Treatment Adoption Analysis
   3.2. Disease Epidemiology
   3.3. Regulatory Landscape
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Analysis
4. Global Autism Spectrum Disorder Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Bn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
       4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
   4.3. Global Autism Spectrum Disorder Treatment Market Outlook: Treatment
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Bn) Analysis, By Treatment, 2019 - 2023
       4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
           4.3.3.1. Behavioral Therapy
           4.3.3.2. Drug Therapy
               4.3.3.2.1. Antipsychotic Drugs
               4.3.3.2.2. Stimulants
               4.3.3.2.3. SSRIs/Antidepressants
               4.3.3.2.4. Others
           4.3.3.3. Complementary & Alternative Therapies
           4.3.3.4. Others
       4.3.4. Market Attractiveness Analysis: Treatment
   4.4. Global Autism Spectrum Disorder Treatment Market Outlook: Indication
       4.4.1. Introduction / Key Findings
       4.4.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019 - 2023
       4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2023 - 2031
           4.4.3.1. Persuasive Developmental Disorder
           4.4.3.2. Autistic Disorder
           4.4.3.3. Asperger Syndrome
           4.4.3.4. Others
       4.4.4. Market Attractiveness Analysis: Indication
   4.5. Global Autism Spectrum Disorder Treatment Market Outlook: End User
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
       4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
           4.5.3.1. Hospitals
           4.5.3.2. Specialized Autism Treatment Centers
           4.5.3.3. Outpatient Care Centers
           4.5.3.4. Homecare Settings
           4.5.3.5. Others
       4.5.4. Market Attractiveness Analysis: End User
5. Global Autism Spectrum Disorder Treatment Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
   5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Autism Spectrum Disorder Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       6.2.1. By Country
       6.2.2. By Treatment
       6.2.3. By Indication
       6.2.4. By End User
   6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
       6.4.1. Behavioural Therapy
       6.4.2. Drug Therapy
           6.4.2.1. Antipsychotic Drugs
           6.4.2.2. Stimulants
           6.4.2.3. SSRIs/Antidepressants
           6.4.2.4. Others
       6.4.3. Complementary & Alternative Therapies
       6.4.4. Others
   6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2023 - 2031
       6.5.1. Persuasive Developmental Disorder
       6.5.2. Autistic Disorder
       6.5.3. Asperger Syndrome
       6.5.4. Others
   6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       6.6.1. Hospitals
       6.6.2. Specialized Autism Treatment Centers
       6.6.3. Outpatient Care Centers
       6.6.4. Homecare Settings
       6.6.5. Others
   6.7. Market Attractiveness Analysis
7. Europe Autism Spectrum Disorder Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       7.2.1. By Country
       7.2.2. By Treatment
       7.2.3. By Indication
       7.2.4. By End User
   7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
       7.4.1. Behavioural Therapy
       7.4.2. Drug Therapy
           7.4.2.1. Antipsychotic Drugs
           7.4.2.2. Stimulants
           7.4.2.3. SSRIs/Antidepressants
           7.4.2.4. Others
       7.4.3. Complementary & Alternative Therapies
       7.4.4. Others
   7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2023 - 2031
       7.5.1. Persuasive Developmental Disorder
       7.5.2. Autistic Disorder
       7.5.3. Asperger Syndrome
       7.5.4. Others
   7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       7.6.1. Hospitals
       7.6.2. Specialized Autism Treatment Centers
       7.6.3. Outpatient Care Centers
       7.6.4. Homecare Settings
       7.6.5. Others
   7.7. Market Attractiveness Analysis
8. East Asia Autism Spectrum Disorder Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       8.2.1. By Country
       8.2.2. By Treatment
       8.2.3. By Indication
       8.2.4. By End User
   8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
       8.4.1. Behavioural Therapy
       8.4.2. Drug Therapy
           8.4.2.1. Antipsychotic Drugs
           8.4.2.2. Stimulants
           8.4.2.3. SSRIs/Antidepressants
           8.4.2.4. Others
       8.4.3. Complementary & Alternative Therapies
       8.4.4. Others
   8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2023 - 2031
       8.5.1. Persuasive Developmental Disorder
       8.5.2. Autistic Disorder
       8.5.3. Asperger Syndrome
       8.5.4. Others
   8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       8.6.1. Hospitals
       8.6.2. Specialized Autism Treatment Centers
       8.6.3. Outpatient Care Centers
       8.6.4. Homecare Settings
       8.6.5. Others
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Autism Spectrum Disorder Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       9.2.1. By Country
       9.2.2. By Treatment
       9.2.3. By Indication
       9.2.4. By End User
   9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
       9.4.1. Behavioural Therapy
       9.4.2. Drug Therapy
           9.4.2.1. Antipsychotic Drugs
           9.4.2.2. Stimulants
           9.4.2.3. SSRIs/Antidepressants
           9.4.2.4. Others
       9.4.3. Complementary & Alternative Therapies
       9.4.4. Others
   9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2023 - 2031
       9.5.1. Persuasive Developmental Disorder
       9.5.2. Autistic Disorder
       9.5.3. Asperger Syndrome
       9.5.4. Others
   9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       9.6.1. Hospitals
       9.6.2. Specialized Autism Treatment Centers
       9.6.3. Outpatient Care Centers
       9.6.4. Homecare Settings
       9.6.5. Others
   9.7. Market Attractiveness Analysis
10. Latin America Autism Spectrum Disorder Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       10.2.1. By Country
       10.2.2. By Treatment
       10.2.3. By Indication
       10.2.4. By End User
   10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
       10.4.1. Behavioural Therapy
       10.4.2. Drug Therapy
           10.4.2.1. Antipsychotic Drugs
           10.4.2.2. Stimulants
           10.4.2.3. SSRIs/Antidepressants
           10.4.2.4. Others
       10.4.3. Complementary & Alternative Therapies
       10.4.4. Others
   10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2023 - 2031
       10.5.1. Persuasive Developmental Disorder
       10.5.2. Autistic Disorder
       10.5.3. Asperger Syndrome
       10.5.4. Others
   10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       10.6.1. Hospitals
       10.6.2. Specialized Autism Treatment Centers
       10.6.3. Outpatient Care Centers
       10.6.4. Homecare Settings
       10.6.5. Others
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Autism Spectrum Disorder Treatment Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       11.2.1. By Country
       11.2.2. By Treatment
       11.2.3. By Indication
       11.2.4. By End User
   11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
       11.4.1. Behavioural Therapy
       11.4.2. Drug Therapy
           11.4.2.1. Antipsychotic Drugs
           11.4.2.2. Stimulants
           11.4.2.3. SSRIs/Antidepressants
           11.4.2.4. Others
       11.4.3. Complementary & Alternative Therapies
       11.4.4. Others
   11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2023 - 2031
       11.5.1. Persuasive Developmental Disorder
       11.5.2. Autistic Disorder
       11.5.3. Asperger Syndrome
       11.5.4. Others
   11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       11.6.1. Hospitals
       11.6.2. Specialized Autism Treatment Centers
       11.6.3. Outpatient Care Centers
       11.6.4. Homecare Settings
       11.6.5. Others
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. F. Hoffmann-La Roche Ltd
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Aurobindo Pharma Ltd.
       12.3.3. Curemark, LLC
       12.3.4. Yamo Pharmaceuticals
       12.3.5. PaxMedica
       12.3.6. Janssen Pharmaceuticals, Inc.
       12.3.7. Teva Pharmaceutical Industries Ltd.
       12.3.8. H. Lundbeck A/S
       12.3.9. Otsuka Holdings Co. Ltd.
       12.3.10. AstraZeneca
       12.3.11. Pfizer, Inc.
       12.3.12. Eli Lilly and Company
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations